- NZ$8.97m
- NZ$7.71m
- NZ$2.43m
Brief: Truscreen Group Said Zerocancer Professional Consult Appointed As Distributor
Brief: Truscreen Group Says Tony Ho To Resume Role As Independent Non-Executive Chairman
New Zealand's TruScreen tumbles on discounted placement
Brief: Truscreen Group Says NZ Regco Has Approved A Trading Halt
Brief: Truscreen Announces Opening Of NZ$2.9 Million Capital Raise
Brief: Truscreen Group Sees FY26 Unaudited Loss
Brief: Truscreen Says Submits Three Proposals To Unitaid's Global Cervical Cancer Elimination Call
Brief: Truscreen Group Sees Total Revenue For Fy2026 To Be Nz$2.7 Million
Brief: Truscreen Group Provides Management Update
Brief: Truscreen Group Says It Signed First Uzbekistan Sales Contract
Brief: NZ Regco Applied A Trading Halt To Ordinary Shares Of Truscreen Group
Brief: NZ Regco Approves Trading Halt Application From Truscreen Group
Brief: Truscreen Group Says NZ$3 Million Capital Raising At NZ$0.022/Share
Brief: Truscreen Seeks Trading Halt In NZX And ASX Shares
Brief: Truscreen Appointed To Distribute Daltonbio's HPV Detection Products In India
Brief: Truscreen Group To Distribute Its Ai Enabled Truscreen Cervical Cancer Screening System In India
Brief: Truscreen Says Changes To US And China Tariff Regimes Have No Impact On Truscreen
Brief: Truscreen Group Sees Revenue For Financial 2025 To Be Circa NZ$1.7 Mln
New Zealand's TruScreen Group hits two-year high on MoU with China-based co